<code id='DC7AD8E654'></code><style id='DC7AD8E654'></style>
    • <acronym id='DC7AD8E654'></acronym>
      <center id='DC7AD8E654'><center id='DC7AD8E654'><tfoot id='DC7AD8E654'></tfoot></center><abbr id='DC7AD8E654'><dir id='DC7AD8E654'><tfoot id='DC7AD8E654'></tfoot><noframes id='DC7AD8E654'>

    • <optgroup id='DC7AD8E654'><strike id='DC7AD8E654'><sup id='DC7AD8E654'></sup></strike><code id='DC7AD8E654'></code></optgroup>
        1. <b id='DC7AD8E654'><label id='DC7AD8E654'><select id='DC7AD8E654'><dt id='DC7AD8E654'><span id='DC7AD8E654'></span></dt></select></label></b><u id='DC7AD8E654'></u>
          <i id='DC7AD8E654'><strike id='DC7AD8E654'><tt id='DC7AD8E654'><pre id='DC7AD8E654'></pre></tt></strike></i>

          fashion

          fashion

          author:hotspot    Page View:3
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          New air purifier tech could be key to improving indoor air quality
          New air purifier tech could be key to improving indoor air quality

          AdobeUntiltheearly20thcentury,Americaregularlyexperiencedbrutallydestructiveurbanfires.Conflagration

          read more
          Why sickle cell disease is getting the first CRISPR treatment
          Why sickle cell disease is getting the first CRISPR treatment

          AdobeNearlyadecadeago,consultantsdeliveredtoRodgerNovakakindofSearscatalogofhumanmalady:200pages,lis

          read more
          Dobbs anniversary: the lost opportunity of abortion as health care
          Dobbs anniversary: the lost opportunity of abortion as health care

          NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

          read more

          A new deal aims to ramp up use of AI in rehab care decisions

          You’rereadingthewebeditionofSTATHealthTech,ourguidetohowtechistransformingthelifesciences. Signuptog